1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
2. Aran V, Victorino AP, Thuler LC, Ferreira CG. Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality. Clin Colorectal Cancer 2016;15:195-203.
3. Zou S, Fang L, Lee MH. Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterol Rep (Oxf) 2018;6:1-12.
4. Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. CELL HOST MICROBE 2014;15:317-28.
5. Kovacs T, Miko E, Ujlaki G, Sari Z, Bai P. The Microbiome as a Component of the Tumor Microenvironment. ADV EXP MED BIOL 2020;1225:137-53.
6. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. NAT REV MICROBIOL 2021;19:55-71.
7. Sarhadi V, Lahti L, Saberi F, Youssef O, Kokkola A, Karla T, Tikkanen M, Rautelin H, Puolakkainen P, Salehi R, Knuutila S. Gut Microbiota and Host Gene Mutations in Colorectal Cancer Patients and Controls of Iranian and Finnish Origin. ANTICANCER RES 2020;40:1325-34.
8. Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, Cording S, Eberl G, Schlitzer A, Ginhoux F, Mani S, Yamazaki T, Jacquelot N, Enot DP, Berard M, Nigou J, Opolon P, Eggermont A, Woerther PL, Chachaty E, Chaput N, Robert C, Mateus C, Kroemer G, Raoult D, Boneca IG, Carbonnel F, Chamaillard M, Zitvogel L. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. SCIENCE 2015;350:1079-84.
9. Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol 2017;14:356-65.
10. Amitay EL, Carr PR, Gies A, Laetsch DC, Brenner H. Probiotic/Synbiotic Treatment and Postoperative Complications in Colorectal Cancer Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin Transl Gastroenterol 2020;11:e268.
11. Gong Y, Dong R, Gao X, Li J, Jiang L, Zheng J, Cui S, Ying M, Yang B, Cao J, He Q. Neohesperidin prevents colorectal tumorigenesis by altering the gut microbiota. PHARMACOL RES 2019;148:104460.
12. Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol 2019;16:605-16.
13. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 2017;14:491-502.
14. Hattori T, Nakagawa T, Maeshima M, Nakamura K, Asahi T. Molecular cloning and nucleotide sequence of cDNA for sporamin, the major soluble protein of sweet potato tuberous roots. PLANT MOL BIOL 1985;5:313-20.
15. Qian CJ, Qi YX, Chen XY, Zeng JP, Yao J. Sporamin suppresses growth of human esophageal squamous cell carcinoma cells by inhibition of NFkappaB via an AKTindependent pathway. MOL MED REP 2017;16:9620-26.
16. Qian C, Chen X, Qi Y, Zhong S, Gao X, Zheng W, Mao Z, Yao J. Sporamin induces apoptosis and inhibits NF-kappaB activation in human pancreatic cancer cells. Tumour Biol 2017;39:1393382747.
17. Yao J, Qian C. Sporamin induce apoptosis in human tongue carcinoma cells by down-regulating Akt/GSK-3 signaling. Fundam Clin Pharmacol 2011;25:229-36.
18. Yang C, Zhang JJ, Zhang XP, Xiao R, Li PG. Sporamin suppresses growth of xenografted colorectal carcinoma in athymic BALB/c mice by inhibiting liver beta-catenin and vascular endothelial growth factor expression. World J Gastroenterol 2019;25:3196-206.
19. Qian CJ, Qi YX, Zhong S, Zeng JP, Chen XY, Yao J. Mitogen-activated protein kinase inhibition enhances the antitumor effects of sporamin in human pancreatic cancer cells. ONCOL LETT 2018;16:1237-42.
20. Zhi-dong, XIONG, And, Peng-gao, LI, And, Tai-hua, MU. The Differentiation- and Proliferation-Inhibitory Effects of Sporamin from Sweet Potato in 3T3-L1 Preadipocytes. Agricultural Sciences in China 2009.
21. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. NAT METHODS 2010;7:335-36.
22. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. BIOINFORMATICS 2011;27:2194-200.
23. Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. NAT METHODS 2013;10:996-98.
24. Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, Brown CT, Porras-Alfaro A, Kuske CR, Tiedje JM. Ribosomal Database Project: data and tools for high throughput rRNA analysis. NUCLEIC ACIDS RES 2014;42:D633-42.
25. Westcott SL, Schloss PD. De novo clustering methods outperform reference-based methods for assigning 16S rRNA gene sequences to operational taxonomic units. PEERJ 2015;3:e1487.
26. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega TR, Knight R, Beiko RG, Huttenhower C. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. NAT BIOTECHNOL 2013;31:814-21.
27. Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. BIOINFORMATICS 2014;30:3123-24.
28. Cock PJA, Fields CJ, Goto N, Heuer ML, Rice PM. The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. NUCLEIC ACIDS RES 2010;38:1767-71.
29. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. NAT METHODS 2012;9:357-59.
30. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC BIOINFORMATICS 2011;12:323.
31. Guda MR, Velpula KK, Asuthkar S, Cain CP, Tsung AJ. Targeting RGS4 Ablates Glioblastoma Proliferation. INT J MOL SCI 2020;21.
32. Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. NAT METHODS 2015;12:59-60.
33. von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, Jouffre N, Huynen MA, Bork P. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. NUCLEIC ACIDS RES 2005;33:D433-37.
34. Killcoyne S, Carter GW, Smith J, Boyle J. Cytoscape: a community-based framework for network modeling. Methods Mol Biol 2009;563:219-39.
35. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009;361:2449-60.
36. McKnite AM, Perez-Munoz ME, Lu L, Williams EG, Brewer S, Andreux PA, Bastiaansen JW, Wang X, Kachman SD, Auwerx J, Williams RW, Benson AK, Peterson DA, Ciobanu DC. Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLOS ONE 2012;7:e39191.
37. van den Elsen LW, Poyntz HC, Weyrich LS, Young W, Forbes-Blom EE. Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases. Clin Transl Immunology 2017;6:e125.
38. Zhou Z, Chen J, Yao H, Hu H. Fusobacterium and Colorectal Cancer. FRONT ONCOL 2018;8:371.
39. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. NATURE 2012;491:254-58.
40. Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, Berenjian A, Ghasemi Y. Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods 2019;8.
41. Cardona F, Andres-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuno MI. Benefits of polyphenols on gut microbiota and implications in human health. J NUTR BIOCHEM 2013;24:1415-22.
42. Touchefeu Y, Duchalais E, Bruley DVS, Alameddine J, Mirallie E, Matysiak-Budnik T, Le Bastard Q, Javaudin F, Rimbert M, Jotereau F, Montassier E. Concomitant decrease of double-positive lymphocyte population CD4CD8alphaalpha and Faecalibacterium prausnitzii in patients with colorectal cancer. Eur J Gastroenterol Hepatol 2021;32:149-56.
43. Hu Y, Le Leu RK, Christophersen CT, Somashekar R, Conlon MA, Meng XQ, Winter JM, Woodman RJ, McKinnon R, Young GP. Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats. CARCINOGENESIS 2016;37:366-75.
44. Ambalam P, Raman M, Purama RK, Doble M. Probiotics, prebiotics and colorectal cancer prevention. Best Pract Res Clin Gastroenterol 2016;30:119-31.
45. Oh NS, Lee JY, Kim YT, Kim SH, Lee JH. Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer. Gut Microbes 2020;12:1785803.
46. Luan Y, Li Y, Yue X, Cao Y, Xiang F, Mao D, Xiong Z. Metabonomics of mice intestine in Codonopsis foetens induced apoptosis of intestine cancer cells. SAUDI J BIOL SCI 2019;26:1003-10.
47. Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Watanabe H, Masuda K, Nishimoto Y, Kubo M, Hosoda F, Rokutan H, Matsumoto M, Takamaru H, Yamada M, Matsuda T, Iwasaki M, Yamaji T, Yachida T, Soga T, Kurokawa K, Toyoda A, Ogura Y, Hayashi T, Hatakeyama M, Nakagama H, Saito Y, Fukuda S, Shibata T, Yamada T. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. NAT MED 2019;25:968-76.
48. Golding BT, Watson WP. Possible mechanisms of carcinogenesis after exposure to benzene. IARC Sci Publ 1999:75-88.
49. Arima K, Lau MC, Zhao M, Haruki K, Kosumi K, Mima K, Gu M, Vayrynen JP, Twombly TS, Baba Y, Fujiyoshi K, Kishikawa J, Guo C, Baba H, Richards WG, Chan AT, Nishihara R, Meyerhardt JA, Nowak JA, Giannakis M, Fuchs CS, Ogino S. Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer. MOL CANCER RES 2020.
50. Castellaro AM, Tonda A, Cejas HH, Ferreyra H, Caputto BL, Pucci OA, Gil GA. Oxalate induces breast cancer. BMC CANCER 2015;15.
51. Shiby VK, Mishra HN. Fermented milks and milk products as functional foods--a review. Crit Rev Food Sci Nutr 2013;53:482-96.
52. Franz CMAP, Holzapfel WH, Stiles ME. Enterococci at the crossroads of food safety?. Netherlands: Elsevier B.V; 1999: 1-24.
53. Metabolic inhibitors of bacterial glycan biosynthesis. CHEM SCI 2020.
54. Akhtar AM, Younis S, Wallerman O, Gupta R, Andersson L, Sjoblom T. Transcriptional modulator ZBED6 affects cell cycle and growth of human colorectal cancer cells. Proc Natl Acad Sci U S A 2015;112:7743-48.
55. Lazarus KA, Hadi F, Zambon E, Bach K, Santolla MF, Watson JK, Correia LL, Das M, Ugur R, Pensa S, Becker L, Campos LS, Ladds G, Liu P, Evan GI, McCaughan FM, Le Quesne J, Lee JH, Calado D, Khaled WT. BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma. NAT COMMUN 2018;9:3327.
56. Park SY, Lee SJ, Cho HJ, Kim JT, Yoon HR, Lee KH, Kim BY, Lee Y, Lee HG. Epsilon-Globin HBE1 Enhances Radiotherapy Resistance by Down-Regulating BCL11A in Colorectal Cancer Cells. Cancers (Basel) 2019;11.
57. Zuehlke AD, Beebe K, Neckers L, Prince T. Regulation and function of the human HSP90AA1 gene. GENE 2015;570:8-16.
58. Brancaccio M, Rocca S, Secli L, Busso E, Fusella F. The double face of Morgana in tumorigenesis. Oncotarget 2015;6:42603-12.
59. Di Savino A, Panuzzo C, Rocca S, Familiari U, Piazza R, Crivellaro S, Carra G, Ferretti R, Fusella F, Giugliano E, Camporeale A, Franco I, Miniscalco B, Cutrin JC, Turco E, Silengo L, Hirsch E, Rege-Cambrin G, Gambacorti-Passerini C, Pandolfi PP, Papotti M, Saglio G, Tarone G, Morotti A, Brancaccio M. Morgana acts as an oncosuppressor in chronic myeloid leukemia. BLOOD 2015;125:2245-53.